Carregant...

Patient selection may affect gene therapy success. Dominant negative effects observed for ornithine transcarbamylase in mouse and human hepatocytes.

We have achieved significant improvement of ornithine transcarbamylase deficiency (OTCD) in a mouse model through adenoviral-mediated gene transfer of the human ornithine transcarbamylase cDNA. Substantial reduction in orotic aciduria was observed within 24 h of treatment. Metabolic correction was l...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Morsy, M A, Zhao, J Z, Ngo, T T, Warman, A W, O'Brien, W E, Graham, F L, Caskey, C T
Format: Artigo
Idioma:Inglês
Publicat: 1996
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC507121/
https://ncbi.nlm.nih.gov/pubmed/8609240
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!